Journal article

ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms

Junya Kuroda, Shinya Kimura, Michael Andreeff, Eishi Ashihara, Yuri Kamitsuji, Asumi Yokota, Eri Kawata, Miki Takeuchi, Ruriko Tanaka, Yoshihide Murotani, Yosuke Matsumoto, Hideo Tanaka, Andreas Strasser, Masafumi Taniwaki, Taira Maekawa

Br. J. Haematol. | WILEY | Published : 2008